Adage Capital Partners GP, L.L.C. 13F Portfolio

CIK 1165408 Filing since Q1 2014 Q2 2026 filed Aug 14, 2026
Holdings as of Jun 30, 2026, from the 13F filed Aug 14, 2026.

Portfolio Snapshot

876 positions · Q2 2026

Adage Capital Partners GP, L.L.C. reported 876 positions worth $70.04B for the quarter ended Jun 30, 2026, up 11.9% on the prior quarter. It opened 125 new positions, added to 283, trimmed 364 and exited 102. Its largest holding is Nvidia Corp at 6.3% of the portfolio.

Portfolio Value
$70.04B
+11.9% QoQ · +24.9% YoY
Positions
876
125 new · 102 sold out
Top 10 Concentration
30%
of portfolio value
Largest Position
NVDA 6.3%
Nvidia Corp
Net Buying
-$1.69B
$7.87B bought · $9.55B sold
Turnover
11.9%
of the portfolio traded
Top Sector
Technology
39.8% of value
Track Record
50
quarters on file since Q1 2014

Portfolio Value & Positions

Value Positions

Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.

Sector Allocation

12 sectors
39.8%
Technology
Technology39.8%
Healthcare13.85%
Financial Services12.1%
Industrials10.01%
Consumer Discretionary7.45%
Energy5.28%
Consumer Staples3.66%
Utilities2.69%
Basic Materials2.04%
Real Estate1.85%
Communication Services1.02%
Other0.256%

Quarterly Buying & Selling

Bought Sold

Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.

Position Changes

How many positions were opened, added to, trimmed or closed each quarter.

Sector Allocation Over Time

Share of reported value in each sector at every quarter end.

TechnologyHealthcareFinancial ServicesIndustrialsConsumer DiscretionaryEnergyConsumer StaplesUtilitiesBasic MaterialsReal EstateCommunication ServicesOther

Largest Buys

Q2 2026
Holding Change Change % Trade Value Weight
DVN Devon Energy Corp +7.61M +904.3% $314.33M 0.498%
MRVL Marvell Technology, Inc. +745.8K – $222.17M 0.317%
SYRE Spyre Therapeutics, Inc. +1.72M – $152.91M 0.218%
UAL United Airlines Holdings, Inc. +983.5K +458.1% $133.75M 0.233%
BBIO BridgeBio Pharma, Inc. +1.65M +276.0% $123.12M 0.239%
DOV DOVER Corp +502.8K +69.7% $112.77M 0.392%
D Dominion Energy, Inc +1.58M – $108.16M 0.154%
AJG Arthur J. Gallagher & Co. +458.2K +134.5% $105.20M 0.262%
SYK Stryker Corp +307.5K – $96.81M 0.138%
MMM 3M Co +583.5K +208.4% $94.48M 0.2%

Largest Sells

Q2 2026
Holding Change Change % Trade Value Weight
RVMD Revolution Medicines, Inc. -4.88M -89.1% $913.62M 0.16%
RPRX Royalty Pharma plc -4.98M -66.6% $279.26M 0.2%
LLY ELI LILLY & Co -230.6K -24.1% $276.61M 1.24%
RBA Rb Global Inc. -2.08M -91.8% $241.74M 0.031%
CSX Csx Corp -4.98M -70.2% $236.56M 0.143%
TNGX Tango Therapeutics, Inc. -7.21M -56.3% $225.37M 0.25%
ALAB Astera Labs, Inc. -365.0K -80.4% $176.30M 0.061%
CVX Chevron Corp -776.2K -31.0% $128.66M 0.408%
BSX Boston Scientific Corp -2.96M -64.0% $126.47M 0.102%
UNM Unum Group -1.35M -67.5% $120.69M 0.083%

New Positions

Q2 2026
Holding Shares Trade Value Weight
MRVL Marvell Technology, Inc. +745.8K $222.17M 0.317%
SYRE Spyre Therapeutics, Inc. +1.72M $152.91M 0.218%
D Dominion Energy, Inc +1.58M $108.16M 0.154%
SYK Stryker Corp +307.5K $96.81M 0.138%
HUM Humana Inc +210.1K $83.46M 0.119%
TEVA Teva Pharmaceutical Industries Ltd +2.36M $79.98M 0.114%
ALKS Alkermes plc. +1.37M $71.68M 0.102%
KLRA Kailera Therapeutics, Inc. +3.21M $70.68M 0.101%
ABSI Absci Corp +5.70M $66.12M 0.094%
ELVN Enliven Therapeutics, Inc. +1.08M $54.98M 0.078%

Closed Positions

Q2 2026
Holding Shares Sold Trade Value Prior Weight
SO Southern Co -1.19M $114.56M 0.183%
VOYA Voya Financial, Inc. -1.50M $102.48M 0.164%
MDGL Madrigal Pharmaceuticals, Inc. -185.3K $97.02M 0.155%
HCA HCA Healthcare, Inc. -116.2K $54.99M 0.088%
DAL Delta Air Lines, Inc. -781.9K $51.98M 0.083%
FE Firstenergy Corp -886.7K $44.92M 0.072%
SHEL Shell plc -480.0K $44.64M 0.071%
THG Hanover Insurance Group, Inc. -215.4K $37.33M 0.06%
SUNB Sunbelt Rentals Holdings, Inc. -565.0K $36.78M 0.059%
FITB Fifth Third Bancorp -776.3K $36.07M 0.058%
Holdings · Q2 2026

876 Positions

As ofJun 30, 2026
Value$70.04B
Top 1030%
Avg position$79.96M
# Activity
861 more holdings Create a free account to keep reading this institution’s full portfolio.
Showing 1–15 of 876 positions 13F filings on SEC EDGAR

Tip. Select a row to see that position’s full history at Adage Capital Partners Gp, L.L.C.

About Adage Capital Partners GP, L.L.C.’s 13F Portfolio

What are Adage Capital Partners GP, L.L.C.’s largest holdings?

As of its Q2 2026 13F filing, Adage Capital Partners GP, L.L.C.’s five largest positions were Nvidia Corp (NVDA) at 6.3%, Apple Inc. (AAPL) at 5.4%, Microsoft Corp (MSFT) at 3.5%, Amazon Com Inc (AMZN) at 3.0%, Alphabet Inc. (GOOGL) at 2.7% of the reported portfolio.

How much is Adage Capital Partners GP, L.L.C.’s portfolio worth?

Adage Capital Partners GP, L.L.C. reported a 13F portfolio worth $70.04B across 876 positions for Q2 2026. That is up 11.9% from the previous quarter.

What did Adage Capital Partners GP, L.L.C. buy in Q2 2026?

Its largest purchases by value were Devon Energy Corp ($314.33M), Marvell Technology, Inc. ($222.17M), Spyre Therapeutics, Inc. ($152.91M). It opened 125 new positions.

What did Adage Capital Partners GP, L.L.C. sell in Q2 2026?

Its largest sales by value were Revolution Medicines, Inc. ($913.62M), Royalty Pharma plc ($279.26M), ELI LILLY & Co ($276.61M). It exited 102 positions entirely.

Where does this data come from?

From the Form 13F-HR reports Adage Capital Partners GP, L.L.C. files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.

Similar-Sized Institutions

by reported 13F value

13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.